Avience Biomedicals share price lists at 90% premium over the IPO price

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Avience Biomedicals made a bumper stock market debut on 25 June, listing at ₹395.20 apiece on the NSE SME platform. This represents a 90 percent premium over the issue price of ₹208. The listing delivered substantial day-one gains for IPO allottees.